1-3 of 3
Cynthia Ma
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Evaluation of Sensitivity to Endocrine Therapy Index (SET2,3) for Response to Neoadjuvant Endocrine Therapy and Longer-Term Breast Cancer Patient Outcomes (Alliance Z1031)

Vera J. Suman, Lili Du, Tanya Hoskin, Meenakshi Anurag, Cynthia Ma, Isabelle Bedrosian, Kelly K. Hunt, Matthew J. Ellis, W. Fraser Symmans
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (15): 3287–3295.
https://doi.org/10.1158/1078-0432.CCR-22-0068
Published: 02 August 2022
View article titled, Evaluation of Sensitivity to Endocrine Therapy Index (SET2,3) for Response to Neoadjuvant Endocrine Therapy and Longer-Term Breast Cancer Patient Outcomes (Alliance Z1031)
Open the PDF for Evaluation of Sensitivity to Endocrine Therapy Index (SET2,3) for Response to Neoadjuvant Endocrine Therapy and Longer-Term Breast Cancer Patient Outcomes (Alliance Z1031) in another window
Includes: Supplementary data
Journal Articles

Phase I/II Trial of Exemestane, Ribociclib, and Everolimus in Women with HR+/HER2− Advanced Breast Cancer after Progression on CDK4/6 Inhibitors (TRINITI-1)

Aditya Bardia, Sara A. Hurvitz, Angela DeMichele, Amy S. Clark, Amelia Zelnak, Denise A. Yardley, Meghan Karuturi, Tara Sanft, Sibel Blau, Lowell Hart, Cynthia Ma, Hope S. Rugo, Das Purkayastha, Stacy Moulder
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2021) 27 (15): 4177–4185.
https://doi.org/10.1158/1078-0432.CCR-20-2114
Published: 01 August 2021
View article titled, Phase I/II Trial of Exemestane, Ribociclib, and Everolimus in Women with HR<sup>+</sup>/HER2<sup>−</sup> Advanced Breast Cancer after Progression on CDK4/6 Inhibitors (TRINITI-1)
Open the PDF for Phase I/II Trial of Exemestane, Ribociclib, and Everolimus in Women with HR<sup>+</sup>/HER2<sup>−</sup> Advanced Breast Cancer after Progression on CDK4/6 Inhibitors (TRINITI-1) in another window
Includes: Supplementary data
Journal Articles

Safety and Preliminary Evidence of Biologic Efficacy of a Mammaglobin-A DNA Vaccine in Patients with Stable Metastatic Breast Cancer

Venkataswarup Tiriveedhi, Natalia Tucker, John Herndon, Lijin Li, Mark Sturmoski, Matthew Ellis, Cynthia Ma, Michael Naughton, A. Craig Lockhart, Feng Gao, Timothy Fleming, Peter Goedegebuure, Thalachallour Mohanakumar, William E. Gillanders
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (23): 5964–5975.
https://doi.org/10.1158/1078-0432.CCR-14-0059
Published: 30 November 2014
View article titled, Safety and Preliminary Evidence of Biologic Efficacy of a Mammaglobin-A DNA Vaccine in Patients with Stable Metastatic Breast Cancer
Open the PDF for Safety and Preliminary Evidence of Biologic Efficacy of a Mammaglobin-A DNA Vaccine in Patients with Stable Metastatic Breast Cancer in another window
Includes: Supplementary data